Ajanta Pharma Limited
AJANTPHARM
Rang in Aktien
#3728
Established in 1973 and headquartered in Mumbai, India, Ajanta Pharma Limited... Established in 1973 and headquartered in Mumbai, India, Ajanta Pharma Limited operates as a specialized pharmaceutical enterprise. This company, along with its subsidiaries, is dedicated to the development, manufacturing, and commercialization of finished dosage forms. Its extensive product range caters to numerous therapeutic categories, such as anti-infectives (antibiotic, anti-malarial), chronic disease management (anti-diabetic, cardiology), women's health (gynecology), pediatrics, respiratory ailments, general health, dermatology, ophthalmology, and pain management. Notable products include multivitamins, antibiotics, eye drops, and cough syrups. Ajanta Pharma boasts a substantial international footprint, operating across India, Africa, other parts of Asia, the United States, and additional global markets. Furthermore, it supplies its pharmaceutical offerings to various government entities, including armed forces, public hospitals, and governmental procurement departments.
Aktienkurs
$36.22
Marktkapitalisierung
$4.53B
Veränderung (1 Tag)
-0.51%
Veränderung (1 Jahr)
30.26%
Land
IN
Handel Ajanta Pharma Limited (AJANTPHARM)
Kategorie
Healthcare
Gewinn für Ajanta Pharma Limited (AJANTPHARM)
Gewinn im Jun 2026 TTM: $164.80M
Laut den aktuellen Finanzberichten von Ajanta Pharma Limited betragen die aktuellen Gewinne des Unternehmens $164.80M. Im Jahr 2024 erzielte das Unternehmen einen Gewinn von $133.59M, eine Steigerung gegenüber dem Gewinn im Jahr 2023, der $90.68M betrug. Die auf dieser Seite angezeigten Gewinne sind die Gewinne vor Zinsen und Steuern, auch bekannt als EBIT.
Gewinnverlauf von Ajanta Pharma Limited von 2005 bis 2026
Gewinn am Ende jedes Jahres
| Jahr | Gewinn | ändert |
|---|---|---|
| 2026 (TTM) | $164.80M | 18.53% |
| 2025 | $139.04M | 4.08% |
| 2024 | $133.59M | 47.31% |
| 2023 | $90.68M | -24.31% |
| 2022 | $119.81M | -2.57% |
| 2021 | $122.97M | 39.52% |
| 2020 | $88.14M | 19.01% |
| 2019 | $74.06M | -22.54% |
| 2018 | $95.62M | -4.34% |
| 2017 | $99.95M | 20.97% |
| 2016 | $82.63M | 13.06% |
| 2015 | $73.08M | 32.80% |
| 2014 | $55.03M | 69.13% |
| 2013 | $32.54M | 81.39% |
| 2012 | $17.94M | 41.32% |
| 2011 | $12.69M | 47.07% |
| 2010 | $8.63M | 46.96% |
| 2009 | $5.87M | -18.63% |
| 2008 | $7.22M | 61.49% |
| 2007 | $4.47M | 39.66% |
| 2006 | $3.20M | 48.67% |
| 2005 | $2.15M | 0.00% |
Gewinn ähnlicher Unternehmen oder Konkurrenten
| Unternehmen | Gewinn | Gewinnunterschied | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | 970.72% |
IN
|
